HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gabriel Capellà Selected Research

Gabriel Capellà Research Topics

Disease

20Neoplasms (Cancer)
10/2021 - 10/2002
11Colorectal Neoplasms (Colorectal Cancer)
09/2016 - 10/2002
3Carcinoma (Carcinomatosis)
09/2016 - 05/2004
3Adenocarcinoma
10/2014 - 01/2005
2Endometrial Neoplasms (Endometrial Cancer)
12/2019 - 01/2019
2Sarcoma (Soft Tissue Sarcoma)
10/2014 - 10/2002
2Carcinogenesis
08/2013 - 05/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
03/2008 - 01/2002
1Thymoma (Thymic Carcinoma)
10/2014
1Inflammation (Inflammations)
09/2014
1Genetic Predisposition to Disease (Genetic Predisposition)
09/2014
1Adenocarcinoma of Lung
12/2013
1Ovarian Neoplasms (Ovarian Cancer)
11/2013
1Intestinal Polyposis (Polyposis, Intestinal)
08/2013
1Glioblastoma (Glioblastoma Multiforme)
09/2012
1Stomach Neoplasms (Stomach Cancer)
05/2012
1Neurofibroma
01/2011
1Choriocarcinoma
05/2009
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
05/2009
1Breast Neoplasms (Breast Cancer)
06/2008
1Neoplasm Metastasis (Metastasis)
06/2007
1Margins of Excision
06/2007
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
09/2006
1Genomic Instability
09/2006
1Aneuploidy (Aneuploid)
11/2005
1Seminoma
02/2005
1Atrophy
02/2005
1Microsatellite Instability
11/2003
1Infections
09/2003

Drug/Important Bio-Agent (IBA)

5DNA (Deoxyribonucleic Acid)IBA
03/2016 - 11/2003
3Proteins (Proteins, Gene)FDA Link
10/2014 - 02/2005
3GemcitabineFDA Link
11/2013 - 01/2005
2Biomarkers (Surrogate Marker)IBA
12/2019 - 01/2019
2Fluorouracil (Carac)FDA LinkGeneric
09/2016 - 01/2002
2Biological ProductsIBA
01/2005 - 02/2003
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
10/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2016
1SurvivinIBA
09/2016
1Tumor Biomarkers (Tumor Markers)IBA
03/2016
1LigandsIBA
12/2014
1AntibodiesIBA
12/2014
1AmphiregulinIBA
12/2014
1TOR Serine-Threonine KinasesIBA
10/2014
1RibonucleoproteinsIBA
10/2014
1Sirolimus (Rapamycin)FDA Link
10/2014
1Interleukin-1 (Interleukin 1)IBA
09/2014
1MicroRNAs (MicroRNA)IBA
12/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013
1proanthocyanidinIBA
08/2013
1AntioxidantsIBA
08/2013
1Dietary FiberFDA Link
08/2013
1Stromal Interaction Molecule 2IBA
09/2012
1MucinsIBA
05/2012
1EnzymesIBA
05/2010
1Cisplatin (Platino)FDA LinkGeneric
05/2009
1Sunitinib (Sutent)FDA Link
05/2009
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2009
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2009
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
05/2009
1Aromatase InhibitorsIBA
06/2008
1Hormones (Hormone)IBA
06/2008
1Androstenedione (4 Androstene 3,17 dione)IBA
06/2008
1Letrozole (Femara)FDA LinkGeneric
06/2008
1ras ProteinsIBA
11/2006
1Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2006
1Mutant Proteins (Protein, Mutant)IBA
11/2006
1Amino AcidsFDA Link
11/2006
1Cyclin BIBA
11/2006
1NucleotidesIBA
04/2006
1prostacyclin synthetase (prostacyclin synthase)IBA
11/2005
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
08/2005
1Dopamine Receptors (Dopamine Receptor)IBA
07/2005
1Eosine Yellowish-(YS) (Eosin)IBA
02/2005
1Hematoxylin (Haematoxylon)IBA
02/2005
15-Methylcytosine (5 Methylcytosine)IBA
01/2005
1Pharmaceutical PreparationsIBA
01/2005
1Protein Kinases (Protein Kinase)IBA
09/2003
1Phosphotransferases (Kinase)IBA
09/2003
1eIF-2 Kinase (eIF 2 Kinase)IBA
09/2003
1adenovirus associated RNA (VA RNA)IBA
09/2003
1Codon (Codons)IBA
10/2002

Therapy/Procedure

4Drug Therapy (Chemotherapy)
10/2015 - 01/2005
2Oncolytic Virotherapy
10/2021 - 09/2003
2Therapeutics
09/2016 - 10/2015
1Intravenous Administration
10/2021
1Combination Drug Therapy (Combination Chemotherapy)
05/2009
1Metronomic Administration
03/2008
1Combined Modality Therapy
05/2004
1Radiotherapy
01/2002